ABVC
Price
$3.23
Change
+$0.33 (+11.38%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
68.27M
PROK
Price
$2.73
Change
-$0.01 (-0.36%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
369.88M
55 days until earnings call
Interact to see
Advertisement

ABVC vs PROK

Header iconABVC vs PROK Comparison
Open Charts ABVC vs PROKBanner chart's image
ABVC BioPharma
Price$3.23
Change+$0.33 (+11.38%)
Volume$1.1K
Capitalization68.27M
ProKidney
Price$2.73
Change-$0.01 (-0.36%)
Volume$7.61K
Capitalization369.88M
ABVC vs PROK Comparison Chart in %
Loading...
ABVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABVC vs. PROK commentary
Sep 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVC is a Buy and PROK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 25, 2025
Stock price -- (ABVC: $2.90 vs. PROK: $2.74)
Brand notoriety: ABVC and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABVC: 33% vs. PROK: 43%
Market capitalization -- ABVC: $68.27M vs. PROK: $369.88M
ABVC [@Biotechnology] is valued at $68.27M. PROK’s [@Biotechnology] market capitalization is $369.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABVC’s FA Score shows that 0 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • ABVC’s FA Score: 0 green, 5 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, ABVC is a better buy in the long-term than PROK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABVC’s TA Score shows that 3 TA indicator(s) are bullish while PROK’s TA Score has 5 bullish TA indicator(s).

  • ABVC’s TA Score: 3 bullish, 5 bearish.
  • PROK’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, PROK is a better buy in the short-term than ABVC.

Price Growth

ABVC (@Biotechnology) experienced а +2.11% price change this week, while PROK (@Biotechnology) price change was +4.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was +10.70%, and the average quarterly price growth was +54.52%.

Reported Earning Dates

PROK is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+4.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PROK($370M) has a higher market cap than ABVC($68.3M). ABVC YTD gains are higher at: 391.525 vs. PROK (62.130). ABVC has higher annual earnings (EBITDA): -3.57M vs. PROK (-157.52M). PROK has more cash in the bank: 295M vs. ABVC (453K). ABVC has less debt than PROK: ABVC (1.59M) vs PROK (4.42M). PROK has higher revenues than ABVC: PROK (527K) vs ABVC (391K).
ABVCPROKABVC / PROK
Capitalization68.3M370M18%
EBITDA-3.57M-157.52M2%
Gain YTD391.52562.130630%
P/E RatioN/AN/A-
Revenue391K527K74%
Total Cash453K295M0%
Total Debt1.59M4.42M36%
FUNDAMENTALS RATINGS
ABVC: Fundamental Ratings
ABVC
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABVCPROK
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
62%
MACD
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 28 days ago
73%
Declines
ODDS (%)
Bearish Trend 22 days ago
90%
Bearish Trend 10 days ago
81%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
72%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
ABVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SFES0.920.01
+1.10%
Safeguard Scientifics, Inc.
PIAIF6.75N/A
N/A
Ping An Insurance (Group) Company of China Ltd.
SHPMF1.53N/A
N/A
Shanghai Pharmaceuticals Holdings Co., Ltd.
TINLY8.86N/A
N/A
Teijin Ltd.
PHYTF11.81N/A
N/A
Pyrophyte Acquisition Corp.

ABVC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVC has been loosely correlated with MRSN. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVC jumps, then MRSN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVC
1D Price
Change %
ABVC100%
+1.05%
MRSN - ABVC
33%
Loosely correlated
-0.14%
CORT - ABVC
28%
Poorly correlated
+4.15%
TENX - ABVC
23%
Poorly correlated
+1.56%
PROK - ABVC
23%
Poorly correlated
-2.49%
SONN - ABVC
23%
Poorly correlated
+4.20%
More

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with BGMS. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then BGMS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
-2.49%
BGMS - PROK
57%
Loosely correlated
+2.59%
MBIO - PROK
51%
Loosely correlated
-4.29%
RLYB - PROK
44%
Loosely correlated
-3.78%
RYTM - PROK
40%
Loosely correlated
-0.30%
NRIX - PROK
39%
Loosely correlated
-2.25%
More